FDC - FDC | Wealthrox

FDC

FDC · Pharma > Pharmaceuticals & Drugs · Chairman: Uday Kumar Gurkar · MD: Mohan A Chandavarkar · Listing date: Aug. 8, 1997 · Employees: 5519 · Mumbai · http://www.fdcindia.com

Stock Price vs Company Growth

0.4%

1.2%

9.8%

9.9%

16.9%

6.0%

10.5%

10y

11.3%

all

15.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 425 0.4%

359

485

Company Overview

Sales

2,078 Cr

Growth: 10.4%

Profit after Tax

274 Cr

Growth: -13.3%

Small Cap

6,920 Cr

P/E: 25.2x

Industry P/E: 31.1x

Fundamentals

Sales (Cr)	₹ 2,078
Growth	10.4%
EBITDA	15.4%
P/S	3.3x
Dividend	1.0%
P/E	25.2x
Book Value	₹ 143
PEG Ratio	2.4x
ROE	12.3%
P/B	3.0x

Shareholding Pattern

Institutions

Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund

2.58 %

Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund

1.49 %

Promoters

Meera Ramdas Chandavarkar

19.36 %

Nandan Mohan Chandavarkar

10.96 %

Nandan Mohan Chandavarkar

10.77 %

Leo Advisors Pvt Ltd

9.13 %

Virgo Advisors Pvt Ltd

6.09 %

Others

Bengal Finance And Investment Pvt Ltd

1.08 %

Iepf

0.15 %

Increase Decrease No change

Company Profile Detailed

FDC Limited is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.

Belongs to (14 Indices) view more

Investors (67)

nse.clea...

tata.val...

leo.advi...

Followers (6)

deepak

nitin2

keerthi